论文信息 - Thrombocytopenia associated with 5-aminosalicylate prodrug, olsalazine: is the devil still there? - 字舞流文

Thrombocytopenia associated with 5-aminosalicylate prodrug, olsalazine: is the devil still there?

Yuefeng Rao | Feiyue Zheng

[1] R. Caprilli,et al. The long journey of salicylates in ulcerative colitis: The past and the future. , 2009, Journal of Crohn's & colitis.

[2] P. Lakatos,et al. Once daily 5-aminosalicylic acid for the treatment of ulcerative colitis; are we there yet? , 2008, Pharmacological research.

[3] A. Komatsuda,et al. Sulfasalazine-induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein–Barr virus , 2008, Clinical Rheumatology.

[4] A. Fioravanti,et al. Sulfasalazine-induced immune thrombocytopenia , 2007, Postgraduate Medical Journal.

[5] M. Proietta,et al. [Ulcerative colitis and thrombocytopenia: a clinical case of fortuitous association?]. , 2007, La Clinica terapeutica.

[6] S. Marušić,et al. Acute interstitial nephritis due to mesalazine , 2005, Nephrology.

[7] C. Naranjo,et al. Advances in the Diagnosis of Adverse Drug Reactions , 1992, Journal of clinical pharmacology.

[8] T. Daneshmend. Mesalazine-associated thrombocytopenia , 1991, The Lancet.

[9] J. Bancroft,et al. Sulfasalazine hypersensitivity with hepatotoxicity, thrombocytopenia, and erythroid hypoplasia. , 1989, Journal of pediatric gastroenterology and nutrition.

[10] J. Peña,et al. Thrombocytopenia and sulfasalazine. , 1985, Annals of internal medicine.